HCA Healthcare, Inc. 8-K

What Happened
HCA Healthcare, Inc. announced its results of operations for the quarter ended June 30, 2026 in a press release issued July 24, 2026 (filed as Exhibit 99.1). The company also disclosed the press release under Regulation FD. On the same date, HCA’s Board declared a quarterly cash dividend of $0.78 per share of common stock, payable September 30, 2026 to shareholders of record at the close of business on September 16, 2026. The Form 8-K was signed by Michael A. Marks, Executive Vice President and Chief Financial Officer.

Key Details

• Press release announcing Q2 2026 results issued and filed as Exhibit 99.1 on July 24, 2026 (Regulation FD disclosure).
• Quarter reported: ended June 30, 2026 (results summarized in the press release).
• Dividend declared: $0.78 per share, payable Sept 30, 2026; record date Sept 16, 2026.
• Form 8-K items reported: 2.02 (results of operations), 7.01 (Regulation FD disclosure), 8.01 (other events – dividend), and 9.01 (exhibits).

Why It Matters
The filing signals material quarterly results are available for investors to review (earnings, revenue, and other operating metrics are in the press release). The declared $0.78 quarterly dividend is a concrete cash return schedule that affects income-oriented investors and factors into total return calculations. Investors should read the July 24 press release for the detailed financials and any management commentary or guidance.